Oliver C. Rothfuss

4.2k total citations · 1 hit paper
18 papers, 3.5k citations indexed

About

Oliver C. Rothfuss is a scholar working on Molecular Biology, Immunology and Neurology. According to data from OpenAlex, Oliver C. Rothfuss has authored 18 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Immunology and 3 papers in Neurology. Recurrent topics in Oliver C. Rothfuss's work include CRISPR and Genetic Engineering (5 papers), Pluripotent Stem Cells Research (4 papers) and Renal and related cancers (4 papers). Oliver C. Rothfuss is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Pluripotent Stem Cells Research (4 papers) and Renal and related cancers (4 papers). Oliver C. Rothfuss collaborates with scholars based in Germany, United States and Switzerland. Oliver C. Rothfuss's co-authors include Fabienne C. Fiesel, Philipp J. Kahle, Sven Geisler, Kira M. Holmström, Wolfdieter Springer, Klaus Schulze‐Osthoff, Thomas Gasser, Nadja Patenge, Frank Eßmann and Eva Alexander and has published in prestigious journals such as Nucleic Acids Research, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Oliver C. Rothfuss

18 papers receiving 3.5k citations

Hit Papers

PINK1/Parkin-mediated mit... 2010 2026 2015 2020 2010 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver C. Rothfuss Germany 16 2.0k 1.6k 766 510 406 18 3.5k
Yushan Zhu China 33 3.1k 1.6× 2.3k 1.4× 382 0.5× 600 1.2× 288 0.7× 66 4.8k
Vinicia Assunta Polito Italy 10 1.4k 0.7× 1.9k 1.2× 282 0.4× 812 1.6× 269 0.7× 11 3.3k
Danielle A. Sliter United States 13 2.0k 1.0× 2.1k 1.3× 591 0.8× 517 1.0× 250 0.6× 13 3.4k
Joo‐Ho Shin South Korea 26 2.1k 1.0× 642 0.4× 1.3k 1.7× 666 1.3× 186 0.5× 74 3.7k
Farah H. Siddiqi United Kingdom 16 1.9k 1.0× 2.5k 1.5× 431 0.6× 732 1.4× 253 0.6× 23 4.3k
Roberta Kiffin Sweden 18 1.2k 0.6× 2.2k 1.3× 487 0.6× 564 1.1× 345 0.8× 30 3.5k
Francesca Nazio Italy 25 1.8k 0.9× 2.0k 1.2× 243 0.3× 377 0.7× 227 0.6× 38 3.1k
Sumihiro Kawajiri Japan 12 2.0k 1.0× 1.6k 1.0× 828 1.1× 545 1.1× 96 0.2× 21 3.2k
Toshihiko Oka Japan 23 3.3k 1.7× 1.1k 0.6× 435 0.6× 538 1.1× 138 0.3× 41 4.0k
Francesco Vetrini United States 13 2.5k 1.3× 3.1k 1.9× 308 0.4× 977 1.9× 359 0.9× 31 5.3k

Countries citing papers authored by Oliver C. Rothfuss

Since Specialization
Citations

This map shows the geographic impact of Oliver C. Rothfuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver C. Rothfuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver C. Rothfuss more than expected).

Fields of papers citing papers by Oliver C. Rothfuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver C. Rothfuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver C. Rothfuss. The network helps show where Oliver C. Rothfuss may publish in the future.

Co-authorship network of co-authors of Oliver C. Rothfuss

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver C. Rothfuss. A scholar is included among the top collaborators of Oliver C. Rothfuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver C. Rothfuss. Oliver C. Rothfuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tammam, Salma N., et al.. (2016). Nuclear delivery of recombinant OCT4 by chitosan nanoparticles for transgene-free generation of protein-induced pluripotent stem cells. Oncotarget. 7(25). 37728–37739. 19 indexed citations
2.
Dannenmann, Benjamin, Simon Lehle, Dominic G. Hildebrand, et al.. (2015). High Glutathione and Glutathione Peroxidase-2 Levels Mediate Cell-Type-Specific DNA Damage Protection in Human Induced Pluripotent Stem Cells. Stem Cell Reports. 4(5). 886–898. 72 indexed citations
3.
Schaefer, Thorsten, Hui Wang, Martina Konantz, et al.. (2015). Molecular and functional interactions between AKT and SOX2 in breast carcinoma. Oncotarget. 6(41). 43540–43556. 33 indexed citations
4.
Dannenmann, Benjamin, et al.. (2015). Novel AKT phosphorylation sites identified in the pluripotency factors OCT4, SOX2 and KLF4. Cell Cycle. 14(23). 3748–3754. 18 indexed citations
5.
Maetzler, Walter, Andrea Pilotto, Anja Apel, et al.. (2014). In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody. Acta Neuropathologica. 128(6). 893–5. 7 indexed citations
6.
Brück, Jürgen, Ivana Glocova, Tobias Sinnberg, et al.. (2014). Sulforaphane Protects from T Cell–Mediated Autoimmune Disease by Inhibition of IL-23 and IL-12 in Dendritic Cells. The Journal of Immunology. 192(8). 3530–3539. 62 indexed citations
7.
Bareiss, Petra M., Anna Paczulla, Hui Wang, et al.. (2013). SOX2 Expression Associates with Stem Cell State in Human Ovarian Carcinoma. Cancer Research. 73(17). 5544–5555. 126 indexed citations
8.
Hildebrand, Dominic G., Eva Alexander, Simon Lehle, et al.. (2013). I kappa B zeta Is a Transcriptional Key Regulator of CCL2/MCP-1. The Journal of Immunology. 190(9). 3 indexed citations
9.
Lehle, Simon, Dominic G. Hildebrand, Michael Becker, et al.. (2013). LORD-Q: a long-run real-time PCR-based DNA-damage quantification method for nuclear and mitochondrial genome analysis. Nucleic Acids Research. 42(6). e41–e41. 45 indexed citations
10.
Alexander, Eva, Dominic G. Hildebrand, Anna Kriebs, et al.. (2013). IκBζ is a regulator for the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence. Journal of Cell Science. 126(Pt 16). 3738–45. 37 indexed citations
11.
Gerst, Felicia, Oliver C. Rothfuss, Martin Heni, et al.. (2013). Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion. Molecular Metabolism. 2(3). 243–255. 16 indexed citations
12.
Hildebrand, Dominic G., Eva Alexander, Sebastian Hörber, et al.. (2013). IκBζ Is a Transcriptional Key Regulator of CCL2/MCP-1. The Journal of Immunology. 190(9). 4812–4820. 77 indexed citations
13.
Konantz, Martina, Maya C. André, Martin Ebinger, et al.. (2012). EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. Leukemia. 27(1). 56–65. 35 indexed citations
14.
Graupner, Vilma, E. A. Alexander, Oliver C. Rothfuss, et al.. (2011). Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level. Cell Death and Differentiation. 18(7). 1130–1139. 58 indexed citations
15.
Ghoreschi, Kamran, Jürgen Brück, Christina Kellerer, et al.. (2011). Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. The Journal of Experimental Medicine. 208(11). 2291–2303. 295 indexed citations
16.
Geisler, Sven, Kira M. Holmström, Fabienne C. Fiesel, et al.. (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biology. 12(2). 119–131. 2297 indexed citations breakdown →
17.
Rothfuss, Oliver C., Heike Fischer, Takafumi Hasegawa, et al.. (2009). Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair. Human Molecular Genetics. 18(20). 3832–3850. 143 indexed citations
18.
Rothfuss, Oliver C., Thomas Gasser, & Nadja Patenge. (2009). Analysis of differential DNA damage in the mitochondrial genome employing a semi-long run real-time PCR approach. Nucleic Acids Research. 38(4). e24–e24. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026